Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2008 | 1 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Six-month compliance with antidepressant medication in the treatment of major depressive disorder.
Int Clin Psychopharmacol. 2008 Jan;23(1):36-42. doi: 10.1097/YIC.0b013e3282f1c1d8.
Int Clin Psychopharmacol. 2008.
PMID: 18090506
Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder.
Fuentes J, Danckaerts M, Cardo E, Puvanendran K, Berquin P, De Bruyckere K, Montoya A, Quail D, Escobar R.
Fuentes J, et al. Among authors: de bruyckere k.
J Clin Psychopharmacol. 2013 Dec;33(6):766-74. doi: 10.1097/JCP.0b013e31829c762b.
J Clin Psychopharmacol. 2013.
PMID: 23963057
Clinical Trial.
Item in Clipboard
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
Bushe C, Sobanski E, Coghill D, Berggren L, De Bruyckere K, Leppämäki S.
Bushe C, et al. Among authors: de bruyckere k.
CNS Drugs. 2016 Apr;30(4):317-34. doi: 10.1007/s40263-016-0323-x.
CNS Drugs. 2016.
PMID: 27055440
Clinical Trial.
Item in Clipboard
What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?
Demyttenaere K, Albert A, Mesters P, Dewé W, De Bruyckere K, Sangeleer M.
Demyttenaere K, et al. Among authors: de bruyckere k.
J Clin Psychiatry. 2005 Jul;66(7):859-63. doi: 10.4088/jcp.v66n0708.
J Clin Psychiatry. 2005.
PMID: 16013901
Item in Clipboard
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
De Bruyckere K, Bushe C, Bartel C, Berggren L, Kan CC, Dittmann RW.
De Bruyckere K, et al.
CNS Drugs. 2016 Jun;30(6):541-58. doi: 10.1007/s40263-016-0346-3.
CNS Drugs. 2016.
PMID: 27224994
Item in Clipboard
Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: an integrated analysis of 15 clinical trials.
Camporeale A, Porsdal V, De Bruyckere K, Tanaka Y, Upadhyaya H, Deix C, Deberdt W.
Camporeale A, et al. Among authors: de bruyckere k.
J Psychopharmacol. 2015 Jan;29(1):3-14. doi: 10.1177/0269881114560183. Epub 2014 Nov 25.
J Psychopharmacol. 2015.
PMID: 25424623
Item in Clipboard
Cite
Cite